The prognostic significance of serum troponin T levels in Crimean–Congo hemorrhagic fever patients

Journal of Medical Virology

Volumn 89, Issue 3, 2017, Pages 408-412

  Yilmaz, Hülya ^a   Yilmaz, Gürdal ^a   Kostakoğlu, Uğur ^b   Yaman, Hüseyin ^c   Örem, Asım ^a   Köksal, İftihar ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^c Kanuni Training and Research Hospital ^*  (Turkey)

Author keywords

CCHF; Crimean Congo hemorrhagic fever; cTn T; troponin T

Indexed keywords

TROPONIN T; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; AGED; BLOOD; CHEMISTRY; DIAGNOSTIC TEST; EVALUATION STUDY; HEMORRHAGE; HEMORRHAGIC FEVER, CRIMEAN; MIDDLE AGED; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SERUM;

ADULT; AGED; BIOMARKERS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HEMORRHAGE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM; TROPONIN T;

EID: 85001697109     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24454     Document Type: Article

References (17)

1. Ammann P, Fehr T, Minder EI, Günter C, Bertel O. 2001. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 27:965–969.
2. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E. 1996. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335:1342–1349.
3. Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M, Gandini C. 2000. Myocardial necrosis in ICU patients with acute noncardiac disease: A prospective study. Intensive Care Med 26:31–37.
4. Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z. 2012. A new perspective to determine the severity of cases with Crimean–Congo hemorrhagic fever. J Vector Borne Dis 49:105–110.
5. Cevik MA, Erbay A, Bodur H, Gülderen E, Baştuğ A, Kubar A, Akinci E. 2008. Clinical and laboratory features of Crimean–Congo hemorrhagic fever: Predictors of fatality. Int J Infect Dis 12:374–379.
6. Dokuzoguz B, Celikbas AK, Gök ŞE, Baykam N, Eroglu MN, Ergönül Ö. 2013. Severity scoring index for Crimean–Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis 57:1270–1274.
7. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. 2006. Analysis of risk-factors among patients with Crimean–Congo haemorrhagic fever virus infection: Severity criteria revisited. Clin Microbiol Infect 12:551–554.
8. King DA, Codish S, Novack V, Barski L, Almog Y. 2005. The role of cardiac troponin I as a prognostic factor in critically ill medical patients: A prospective observational cohort study. Crit Care 9:390–395.
9. Lazzeri C, Bonizzoli M, Cianchi G, Gensini GF, Peris A. 2008. Troponin I in the intensive care unit setting: From the heart to the heart. Intern Emerg Med 3:9–16.
10. Lee IK, Lee WH, Liu JW, Yang KD. 2010. Acute myocarditis in dengue hemorrhagic fever: A case report and review of cardiac complications in dengue-affected patients. Int J Infect Dis 14:e919–922.
11. Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, Crowther MA, Cook DJ. 2006. Elevated cardiac troponin measurements in critically ill patients. Arc Intern Med 166:2446–2454.
12. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, Robertson DH, Hille DA, DeLucca PT, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E; TACTICS-TIMI 18 Investigators. 2001. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial. JAMA 286:2405–2412.
13. Ozsu S, Yilmaz G, Yilmaz I, Oztuna F, Bulbul Y, Ozlu T. 2011. C-reactive protein alone or combined with cardiac troponin T for risk stratification of respiratory intensive care unit patients. Respir Care 56:1002–1008.
14. Roongsritong C, Warraich I, Bradley C. 2004. Common causes of troponin elevations in the absence of acute myocardial infarction: Incidence and clinical significance. Chest 125:1877–1884.
15. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. 1989. The clinical pathology of Crimean–Congo hemorrhagic fever. Rev Infect Dis 11:794–800.
16. Whitehouse CA. 2004. Crimean–Congo hemorrhagic fever. Antivir Res 64:144–160.
17. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F. 2010. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean–Congo hemorrhagic fever: Severity prediction criteria. J Clin Virol 47:361–365.